FDA Informed Consent Nursing Homes Public Health 
Hall Render
FEBRUARY 10, 2023
over Claims Practices Where things stand in Central California 1 month after a community hospital’s closure California hospital names Kelly Linden CEO Upcoming California health bills to watch, including a conversation with Rep. billion since pandemic U.S. Blue Shield of California is counting on it.
Drug & Device Law
DECEMBER 29, 2023
Since the FDA requires pre-approval of any warnings about off-label uses, preemption at some point should have been pre-ordained under the Mensing ( 2011+1 ) independence principle, but off-label use did not really figure in Zofran ’s analysis. The FDA’s five reviews of teratogenic risk all came to the same conclusion.
Expert insights. Personalized for you.
40 
Let's personalize your content